QNTM - Quantum BioPharma Quarterly EPS earnings growth
Quantum BioPharma Ltd is developing innovative treatments through scientific partnerships, which impacts the quarterly EPS growth rate. Price action on the GURU.Markets chart confirms that 84.80 is establishing a new level. However, regulatory complexities in the bio sector create risks, although the readiness of production capacities and laboratory calibration provide a stable foundation for future business scaling.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_QNTM_-_Quantum-BioPharma-Ltd_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "quantumbiopharma.com (QNTM): Year-over-year earnings per share growth for the last twelve months from 08/16/2024 to 11/13/2026 | 👁️GURU.Markets👁️")
QNTM (Quantum BioPharma Corp): analytical breakdowns and indicator data
- share price and expert price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Total Debt to Equity Ratio Quantum BioPharma Ltd|QNTM - Long-Term Debt to Capital|Short-Term Debt to Capital Quantum BioPharma Ltd|QNTM - Company Aggregate Debts|Debt to Book Capitalization Ratio Quantum BioPharma Limited|QNTM - Company Long-Term Indebtedness|Company Current Liabilities Quantum BioPharma|Quick Liquidity Indicator quantumbiopharma.com
- earnings and market multiples details:
QNTM - Net Profit|Expected Profit Quantum BioPharma Ltd|QNTM - Price to Earnings Ratio|Projected Price to Earnings Quantum BioPharma Limited|QNTM - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Quantum BioPharma Limited|QNTM - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Quantum BioPharma|QNTM - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months quantumbiopharma.com|QNTM - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Quantum BioPharma Ltd
- sales revenue and business income indicators:
Initial company analysis:Quantum BioPharma Ltd
For Quantum BioPharma Ltd (QNTM), which develops neuroprotection and pain management formulas, quarterly net income per share dynamics serve as an indicator of the commercialization of scientific research. This metric measures the percentage change in earnings per share, allowing investors to assess the actual efficiency of the business; however, acquiring assets at the peak of growth rates often leads to overpayment.
Key competitors
HLN: Quarterly EPS earnings growth|Kenvue Inc - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Jyong Bio MENS|Year-over-year earnings per share growth for the last twelve months Ligand Pharmaceuticals (LGND)|AMRX (amneal.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Perrigo PRGO|Net earnings per share growth for the trailing year Alvotech S.A.|LQDA: Year-over-year net earnings per share growth for the last 12 months|GLPG - Quarterly EPS earnings growth|ANIP: Quarterly EPS earnings growth|mannkindcorp.com (MNKD) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Amphastar Pharmaceuticals, Inc.|Year-over-year earnings per share growth for the last 12 months PCRX (Pacira Pharmaceuticals)|Year-over-year net earnings per share growth for the last 12 months SPRY (ARS Pharma)|Year-over-year earnings per share growth rate for the last twelve months TBPH|Aquestive Therapeutics - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth scPharmaceuticals, Inc. SCPH|TECX - Year-over-year earnings per share growth for the last twelve months|Tonix Pharma (TNXP) - Year-over-year net earnings per share growth for the last 12 months|SXTC (sxtchina.com) - Year-over-year net earnings per share growth for the last 12 months|Eupraxia Pharmaceuticals Inc. - Year-over-year earnings per one share growth for the last 12 months|BHST (BioHarvest Sciences) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months EXOZ|Quarterly EPS earnings growth ORMP|Year-over-year net earnings per share change for the last twelve months enterabio.com|Year-over-year earnings per share growth for the last twelve months MindWalk HYFT|ABVC BioPharma, Inc (ABVC) - Earnings per share growth in annualized terms for the last twelve months|CPIX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months FGEN|TELO: Quarterly EPS earnings growth|Rani Therapeutics Holdings, Inc. - Year-over-year earnings per one share growth for the last 12 months|SNYR (Synergy CHC Corp.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Rallybio Corp.|Year-over-year earnings per share growth for the last twelve months Lexaria Bioscience (LEXX)|PULM (pulmatrix.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Pheton Holdings PTHL|APM - Year-over-year net earnings per share growth for the last 12 months|Lyra Therapeutics, Inc - Quarterly EPS earnings growth|IBO - Quarterly EPS earnings growth|TNFA (tnfpharma.com) - Year-over-year net earnings per share growth for the last 12 months|cbdMD - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months PainReform|Year-over-year earnings per share growth for the last twelve months CYTO|Year-over-year net earnings per share growth for the last 12 months LIPO (Lipella)|Year-over-year earnings per share growth rate for the last twelve months OPTN|Quarterly EPS earnings growth PIRS (Pieris Pharmaceuticals)|PROC: Year-over-year earnings per share growth for the last 12 months|PTPI - Year-over-year earnings per share growth for the last twelve months|Net earnings per share growth for the trailing year Qilian International Holding Group (QLI)|ACELYRIN, Inc. (SLRN) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months TFFP
